Back to Results
First PageMeta Content
Artemisinin / Combination drugs / Malaria / Amyris / Antimalarial medication / Semisynthesis / Artesunate / Artemisia annua / ASAQ / Medicine / Health / Chemistry


PRESS RELEASE First antimalarial treatments produced with semisynthetic artemisinin enter market - First shipment marks a critical step in improving access to treatment worldwide Paris, France, and South San Francisco,
Add to Reading List

Document Date: 2014-10-09 14:57:06

Open Document

File Size: 38,76 KB

Share Result on Facebook

City

South San Francisco / New York / Paris / /

Company

PATH / GenoClipp Biotechnology BV / Sanofi / Genzyme / /

Continent

Asia / Africa / /

Country

Congo / France / United States / Niger / Italy / Burkina Faso / Burundi / Nigeria / Liberia / Morocco / /

Event

Business Partnership / Company Listing Change / /

Facility

Sanofi’s distribution centre / National Research Council Canada Plant Biotechnology Institute / University of California / /

IndustryTerm

therapeutic solutions / consumer healthcare / healthcare / synthetic biology technology / stronger artemisinin supply chain / diabetes solutions / /

MedicalCondition

malaria / diabetes / diseases / infection / /

Organization

Melinda Gates Foundation / National Research Council Canada Plant Biotechnology Institute / World Health Organization / UC Berkeley / University of California / Berkeley / /

Person

Robert Sebbag / Steve Davis / /

Position

President and CEO / vice president / pricing model / and supplying it / leader in global health innovation / global healthcare leader / /

ProvinceOrState

California / /

Technology

Biotechnology / synthetic biology technology / therapeutic solutions / Drug Development / /

URL

www.path.org / http /

SocialTag